Nymox Pharmaceutical Corporation {NASDAQ: NYMX} Director James Robinson bought 20,500 shares of Nymox in the market.

Robinson now holds 2.7 million shares in the company.

Nymox Pharmaceutical Corporation {NASDAQ: NYMX} Director James Robinson bought 20,500 shares of Nymox Pharmaceutical Corp stock in a transaction that occurred on Friday, April 1st.

Robinson bought the stock at an average price of $2.40 per share, with a total value of $49,200.00. Following the completion of the acquisition, the director now owns 2,701,050 shares in the company, valued at approximately $6,482,520. 

This is on the back of a recent trade where Robinson purchased 40,000 shares on march 24th 2016. Those shares were bought at an average cost of $2.29 per share, with a total value of $91,600.00.